• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Venous mapping using venography and the risk of radiocontrast-induced nephropathy.

作者信息

Asif Arif, Cherla Gautam, Merrill Donna, Cipleu Cristian D, Tawakol Jan Bijan, Epstein David L, Lenz Oliver

机构信息

Division of Nephrology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida 33136, USA.

出版信息

Semin Dial. 2005 May-Jun;18(3):239-42. doi: 10.1111/j.1525-139X.2005.18319.x.

DOI:10.1111/j.1525-139X.2005.18319.x
PMID:15934971
Abstract

Venous mapping using venography has been considered to be the gold standard for identifying veins suitable for arteriovenous fistula (AVF) creation. By utilizing a radiocontrast medium, however, venography introduces the risk of radiocontrast-induced nephropathy. The risk of this complication in the chronic kidney disease (CKD) population has not been previously studied. Twenty-five consecutive patients (CKD stage 4 and 5) undergoing venography were enrolled in this study. Patients were advised not to fast for the procedure and were encouraged to take oral fluids. Radiocontrast-induced nephropathy was defined as a 20% decrease in the estimated glomerular filtration rate (GFR) from the baseline value at 48 hours after contrast administration. Weekly telephone calls were made for a total of 4 weeks to assess the need for dialysis. Venography was performed by interventional nephrology using 10-20 cc of low osmolarity contrast medium. Data were collected prospectively. Median age was 48.9 +/- 7.8 years and 52% of the patients had diabetes. Complete sets of pre- and postprocedure GFRs were available in 21 patients. At 48 hours, there were no differences between the pre- and postprocedure GFRs. At the third week, one patient developed flu-like symptoms with severe gastroenteritis and was hospitalized for volume depletion. This patient initiated dialysis during the hospital stay. We conclude that at 48 hours, our cohort did not develop radiocontrast-induced nephropathy. During the 4-week phone call follow-up, only one patient needed dialysis. Large-scale studies with a longer follow-up using GFR estimation are needed to confirm these preliminary findings.

摘要

相似文献

1
Venous mapping using venography and the risk of radiocontrast-induced nephropathy.
Semin Dial. 2005 May-Jun;18(3):239-42. doi: 10.1111/j.1525-139X.2005.18319.x.
2
Safety of low-dose radiocontrast for interventional AV fistula salvage in stage 4 chronic kidney disease patients.
Kidney Int. 2006 Apr;69(8):1444-9. doi: 10.1038/sj.ki.5000276.
3
Post-coronarography application of continuous veno-venous hemofiltration in the prevention of contrast nephropathy in patients with complex multisystem deficiency.冠状动脉造影术后持续静脉-静脉血液滤过在预防复杂多系统功能不全患者造影剂肾病中的应用
In Vivo. 2008 Jan-Feb;22(1):123-9.
4
Overutilization of central venous catheters in incident hemodialysis patients: reasons and potential resolution strategies.新发血液透析患者中心静脉导管的过度使用:原因及潜在解决策略
Semin Dial. 2006 Nov-Dec;19(6):543-50. doi: 10.1111/j.1525-139X.2006.00220.x.
5
Small dose contrast venography as venous mapping in predialysis patients.小剂量造影剂静脉造影在透析前患者静脉定位中的应用
J Vasc Access. 2010 Apr-Jun;11(2):122-7. doi: 10.1177/112972981001100207.
6
Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.CONTRAST研究的设计与原理——一项关于甲磺酸非诺多泮预防放射性造影剂肾病的前瞻性、随机、安慰剂对照试验
Rev Cardiovasc Med. 2001;2 Suppl 1:S31-6.
7
Does renin-angiotensin aldosterone system blockade exacerbate contrast-induced nephropathy in patients with chronic kidney disease? A prospective 50-month Mayo Clinic study.肾素-血管紧张素-醛固酮系统阻断是否会加重慢性肾病患者的造影剂肾病?一项为期50个月的梅奥诊所前瞻性研究。
Ren Fail. 2008;30(1):67-72. doi: 10.1080/08860220701742153.
8
The safety of gadolinium in patients with stage 3 and 4 renal failure.钆在3期和4期肾衰竭患者中的安全性。
Nephrol Dial Transplant. 2006 Mar;21(3):697-700. doi: 10.1093/ndt/gfi304. Epub 2005 Dec 2.
9
Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy.多巴胺-1受体激动剂:对肾脏的影响及其在放射性造影剂所致肾病管理中的潜在作用。
J Clin Pharmacol. 2004 Dec;44(12):1342-51. doi: 10.1177/0091270004269842.
10
Radiocontrast-induced nephropathy.放射性造影剂所致肾病
Nephrol Dial Transplant. 1994;9 Suppl 4:146-56.

引用本文的文献

1
Pre-procedure imaging planning for dialysis access in patients with end-stage renal disease using ultrasound and upper extremity computed tomography angiography: a narrative review.使用超声和上肢计算机断层血管造影术对终末期肾病患者进行透析通路术前成像规划:一项叙述性综述。
Cardiovasc Diagn Ther. 2023 Feb 28;13(1):122-132. doi: 10.21037/cdt-21-797. Epub 2022 May 5.
2
Vascular Access Practice Patterns in Canada: A National Survey.加拿大的血管通路实践模式:一项全国性调查。
Can J Kidney Health Dis. 2018 Feb 28;5:2054358118759675. doi: 10.1177/2054358118759675. eCollection 2018.
3
Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy.
前列地尔可保护接受二甲双胍治疗的2型糖尿病患者免受造影剂肾病的影响。
Int Urol Nephrol. 2017 Nov;49(11):2019-2026. doi: 10.1007/s11255-017-1639-2. Epub 2017 Jun 27.
4
Estimating the Risk of Radiocontrast-Associated Nephropathy.评估放射性造影剂相关性肾病的风险。
J Am Soc Nephrol. 2017 Feb;28(2):653-659. doi: 10.1681/ASN.2016010021. Epub 2016 Sep 29.
5
Letter to the Editor re: Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?致编辑的信:静脉注射造影剂真的比动脉内注射的肾毒性小吗?
Eur Radiol. 2013 May;23(5):1260-3. doi: 10.1007/s00330-012-2720-y. Epub 2013 Feb 1.
6
Standardized definitions for hemodialysis vascular access.血液透析血管通路的标准化定义。
Semin Dial. 2011 Sep-Oct;24(5):515-24. doi: 10.1111/j.1525-139X.2011.00969.x. Epub 2011 Sep 9.
7
Vascular mapping: does it help to maximize fistulae placement?血管造影:它有助于使动静脉内瘘的放置最大化吗?
Adv Chronic Kidney Dis. 2009 Sep;16(5):316-20. doi: 10.1053/j.ackd.2009.06.007.